Hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, with incidence rising is expected to increase by another 81% by the year 2020, primarily due to the hepatitis C epidemic. The strongest risk factors for the development of HCC is a hepatitis B (HBV) and hepatitis C (HCV) virus infection, as well as cirrhosis of any cause. Other risk factors that have been reported include exposure to aflatoxin, alcohol, tobacco, obesity and diabetes.
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Background Hepatocellular carcinoma (HCC) is now the third leading cause of cancer deaths worldwide, with over 500,000 people affected, while hepatocellular carcinoma was the fifth most common causes of cancer deaths worldwide in 2005. In the United (1) States and Europe the incidence of HCC is rising, and is expected to increase by another 81% by the year 2020, primarily due to the hepatitis C epidemic . (2) T h e s t r o n g e s t r i s k f a c t o r s f o r t h e development of HCC is a hepatitis B (HBV) and hepatitis C (HCV) virus infection, as well as cirrhosis of any cause . Other risk factors (3) that have been reported include exposure to aflatoxin , alcohol, tobacco, obesity and (4) (5) diabetes . Hepatocellular carcinoma has (6) been well documented to cluster within families , but this has been primarily in (7, 8) regions where HBV is endemic and may have been related to a high prevalence of chronic HBV infection in those families. Only one case-control study of family history and HCC has been performed in an area with a low prevalence of HBV, involving 287 cases and 450 controls in northern Italy . (9) A family history of cancer of any type did not appear to increase the risk of having HCC, suggesting a genetic defect specific for the liver rather than mutation of a widely expressed tumor suppressor gene such as p53 or DNA synthesis gene such as (10) thymidylate synthase . (11) Having a sibling with HCC appear to confer a much higher risk than having a parent with HCC suggesting the possibility of a recessive inheritance pattern. While these two observations seem to support a role for genetic factors, it is also possible than environmental factors, e.g. dietary habits or exposure to carcinogens such as aflatoxin may contribute to familial clustering of HCC.
Cirrhosis due to non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly important cause of HCC . Numerous studies (12) 
Matherial and methods
I. Enrollment and Follow-up
Outpatients meeting the following criteria were enrolled in the study: 
II. Serologic Evaluation
Routine serum biochemical tests were carried out with automated techniques. Persistence of AFP in the mother following birth is a rare hereditary condition. Neonates 
III. Lifestyle Habits and Medical History
Information about cigarette smoking, alcohol drinking, the medical history, and family history of liver cancer was obtained at the time of enrollment through interviews by experienced public health doctors, using a medical questionnaire.
IV. Diagnosis of Liver Cancer
Space-occupying lesions detected or suspected at the time of ultrasonography or alpha-fetoprotein measurement were further examined with computed tomography, fineneedle aspiration biopsy , and other clinical (14) diagnostic techniques such as hepatic scintigraphy, unless the ultrasonographic findings confirmed that the lesions were unquestionably benign (e.g., hemangiomas or cysts). A final diagnosis of hepatocellular carcinoma was based on histologic findings in resected hepatic tumors or biopsy specimens.
In spite of great efforts to prevent patients from dropping out of the study, some withdrew because they were transferred to other hospitals, declined to undergo the periodic examinations, or moved from the Bucharest area.
V. Histological Evaluation of the Liver
The specimens of liver tissue were fixed in 10 percent formalin and routinely stained with hematoxylin and eosin. Hepatocellular carcinoma was diagnosed according to internationally accepted criteria, on the basis of the existence of a pattern of invasive growth or replacing growth . Nodular (15) lesions with none of these abnormal features w e re d e f i n e d a s l a rg e re g e n e r a t i v e nodules . 
VI. Statistical Analysis
The method of Kaplan and Meier was used (18) to estimate the cumulative risk of liver cancer according to the clinical stage of liver disease at enrollment. Cox proportional-hazards regression analysis was performed to (19) estimate rate ratios for possible risk factors 
Results
I. Characteristics at Enrollment
Therese is the basic characteristics of the patients at enrollment (Table 1) Table 1 were similar with respect to sex 
II. Development of Liver Cancer
During A log-rank test of the two curves showed a significant difference between these groups (P<0.001). Among the patients with chronic hepatitis, those who had an elevated alphafetoprotein level at enrollment were at significantly higher risk for liver cancer than those who had a normal level (P<0.001 by log-rank test); the three-year cumulative risk was 10.2 ±2.7 percent in the former and 2.9
III.Cumulative Risk of Liver Cancer
±0.8 percent in the latter.
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Internal Medicine 2018 vol. XV No. -www.srmi.ro 6 The adjusted rate ratios for HBsAg, anti-HBc, and anti-HCV were estimated to be 6.92, 4.54, and 4.09, respectively. Patients whose status for anti-HCV was unknown appeared to have an elevated risk of liver cancer, but this finding was considered an artifact. Since 11 patients who had liver cancer before April 2016 left the study before the test for anti-HCV became available at our institutions, their status for anti-HCV necessarily remained unknown.
Smoking and drinking were also possible risk factors for liver cancer, since many case-control studies and a few cohort (20, 21, 22, 23, 24) studies have indicated a relation between (25, 26) these lifestyle factors and the risk of liver 
